Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Use of levofloxacin in the hospital].
Castells X, Vallano A, Campany D, Rigau D, Arnau JM. Castells X, et al. Among authors: campany d. Rev Esp Quimioter. 2003 Jun;16(2):221-6. Rev Esp Quimioter. 2003. PMID: 12973461 Free article. Spanish.
[Acanthamoeba sp. keratitis in a patient not wearing contact lenses].
Fernández E, Campany D, Grau S. Fernández E, et al. Among authors: campany d. Enferm Infecc Microbiol Clin. 2001 Mar;19(3):133-4. doi: 10.1016/s0213-005x(01)72585-2. Enferm Infecc Microbiol Clin. 2001. PMID: 11333592 Spanish. No abstract available.
Voriconazole and tamsulosin: A clinically relevant drug-drug interaction.
Parramón-Teixidó CJ, Pau-Parra A, Burgos J, Campany D. Parramón-Teixidó CJ, et al. Among authors: campany d. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Aug-Sep;39(7):361-363. doi: 10.1016/j.eimce.2021.05.005. Epub 2021 May 15. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34353519 No abstract available.
Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.
Kirkegaard-Biosca C, Del Barrio-Tofiño E, Villamarín M, Larrosa N, Campany D, González-López JJ, Ferrer R, Viñado B, Doménech L, Sellarès-Nadal J, Escolà-Vergé L, Fernández-Hidalgo N, Los-Arcos I. Kirkegaard-Biosca C, et al. Among authors: campany d. Antibiotics (Basel). 2024 Sep 12;13(9):874. doi: 10.3390/antibiotics13090874. Antibiotics (Basel). 2024. PMID: 39335047 Free PMC article.
Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections.
Escolà-Vergé L, Pigrau C, Los-Arcos I, Arévalo Á, Viñado B, Campany D, Larrosa N, Nuvials X, Ferrer R, Len O, Almirante B. Escolà-Vergé L, et al. Among authors: campany d. Infection. 2018 Aug;46(4):461-468. doi: 10.1007/s15010-018-1133-5. Epub 2018 Mar 28. Infection. 2018. PMID: 29594953
Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria.
Rubiñan P, Viñado B, Fernández-Hidalgo N, Larrosa N, Sempere A, Campany D, Rodríguez-Pardo D, González-López JJ, Nuvials X, Del Barrio-Tofiño E, Escolà-Vergé L, Los-Arcos I. Rubiñan P, et al. Among authors: campany d. Antibiotics (Basel). 2024 Nov 26;13(12):1138. doi: 10.3390/antibiotics13121138. Antibiotics (Basel). 2024. PMID: 39766528 Free PMC article.
20 results